Raymond James Financial »

Eliem Therapeutics shares owned by Raymond James Financial

Quarter-by-quarter ownership of Eliem Therapeutics (CLYM) shares owned by Raymond James Financial from 13F filings

Historical chart of Raymond James Financial investment in Eliem Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Eliem Therapeutics held by Raymond James Financial consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Eliem Therapeutics by Raymond James Financial

Quarter filed Position value Share count Share price at filing
2026-03-31 $121k 18k 6.85
2025-06-30 $248 200 1.24

More positions owned by Raymond James Financial

Vanguard Index Fds S&p 500 Etf Shs (VOO)
Ishares Tr Core Us Aggbd Et (AGG)
Apple (AAPL)
Microsoft Corporation (MSFT)
NVIDIA Corporation (NVDA)
Broadcom (AVGO)
Amazon (AMZN)
JPMorgan Chase & Co. (JPM)
Ishares Tr Core Msci Eafe (IEFA)
Alphabet Cap Stk Cl A (GOOGL)
State Str Spdr S&p 500 Etf T Tr Unit (SPY)
Wal-Mart Stores (WMT)
Ishares Tr Core S&p500 Etf (IVV)
Johnson & Johnson (JNJ)
Ishares Tr Core S&p Mcp Etf (IJH)

View all positions for Raymond James Financial

Top funds holding Eliem Therapeutics

RA Capital Management
MPM Oncology Impact Management
Braidwell
Dr. Jeffrey R. Jay, M.D.
Millennium Management
Vanguard Capital Management
Kynam Capital Management
Marshall Wace
Affinity Asset Advisors
Silverarc Capital Management
Driehaus Capital Management
ADAR1 Capital Management
Susquehanna International
Nan Fung Trinity
Sphera Funds Management

View all funds holding Eliem Therapeutics